List of Tables
Table 1. Global Recombinant Human Anti-RSV Antibody(AM14) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Recombinant Human Anti-RSV Antibody(AM14) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Recombinant Human Anti-RSV Antibody(AM14) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Recombinant Human Anti-RSV Antibody(AM14) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Recombinant Human Anti-RSV Antibody(AM14), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Human Anti-RSV Antibody(AM14), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Human Anti-RSV Antibody(AM14), Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Human Anti-RSV Antibody(AM14), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Human Anti-RSV Antibody(AM14) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Anti-RSV Antibody(AM14) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Anti-RSV Antibody(AM14) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Region (2020-2025) & (K Units)
Table 18. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Region (2020-2025)
Table 19. Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Region (2026-2031) & (K Units)
Table 20. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Region (2026-2031)
Table 21. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Region (2020-2025)
Table 23. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Region (2026-2031)
Table 25. North America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2020-2025) & (K Units)
Table 27. North America Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2026-2031) & (K Units)
Table 28. North America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2020-2025) & (K Units)
Table 32. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2026-2031) & (K Units)
Table 33. Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units) by Type (2020-2025)
Table 51. Global Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units) by Type (2026-2031)
Table 52. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Type (2020-2025)
Table 53. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Type (2026-2031)
Table 54. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Type (2020-2025)
Table 57. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Type (2026-2031)
Table 58. Global Recombinant Human Anti-RSV Antibody(AM14) Price (US$/Unit) by Type (2020-2025)
Table 59. Global Recombinant Human Anti-RSV Antibody(AM14) Price (US$/Unit) by Type (2026-2031)
Table 60. Global Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units) by Application (2020-2025)
Table 61. Global Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units) by Application (2026-2031)
Table 62. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Application (2020-2025)
Table 63. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Application (2026-2031)
Table 64. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Application (2020-2025)
Table 67. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Application (2026-2031)
Table 68. Global Recombinant Human Anti-RSV Antibody(AM14) Price (US$/Unit) by Application (2020-2025)
Table 69. Global Recombinant Human Anti-RSV Antibody(AM14) Price (US$/Unit) by Application (2026-2031)
Table 70. Creative Biolabs Company Information
Table 71. Creative Biolabs Description and Business Overview
Table 72. Creative Biolabs Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Creative Biolabs Recombinant Human Anti-RSV Antibody(AM14) Product
Table 74. Creative Biolabs Recent Developments/Updates
Table 75. Cambridge Biologics Company Information
Table 76. Cambridge Biologics Description and Business Overview
Table 77. Cambridge Biologics Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Cambridge Biologics Recombinant Human Anti-RSV Antibody(AM14) Product
Table 79. Cambridge Biologics Recent Developments/Updates
Table 80. Leading Biology Company Information
Table 81. Leading Biology Description and Business Overview
Table 82. Leading Biology Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Leading Biology Recombinant Human Anti-RSV Antibody(AM14) Product
Table 84. Leading Biology Recent Developments/Updates
Table 85. Biovision Company Information
Table 86. Biovision Description and Business Overview
Table 87. Biovision Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Biovision Recombinant Human Anti-RSV Antibody(AM14) Product
Table 89. Biovision Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Recombinant Human Anti-RSV Antibody(AM14) Distributors List
Table 93. Recombinant Human Anti-RSV Antibody(AM14) Customers List
Table 94. Recombinant Human Anti-RSV Antibody(AM14) Market Trends
Table 95. Recombinant Human Anti-RSV Antibody(AM14) Market Drivers
Table 96. Recombinant Human Anti-RSV Antibody(AM14) Market Challenges
Table 97. Recombinant Human Anti-RSV Antibody(AM14) Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Human Anti-RSV Antibody(AM14)
Figure 2. Global Recombinant Human Anti-RSV Antibody(AM14) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Human Anti-RSV Antibody(AM14) Market Share by Type: 2024 & 2031
Figure 4. >90% Product Picture
Figure 5. >95% Product Picture
Figure 6. >98% Product Picture
Figure 7. Others Product Picture
Figure 8. Global Recombinant Human Anti-RSV Antibody(AM14) Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Recombinant Human Anti-RSV Antibody(AM14) Market Share by Application: 2024 & 2031
Figure 10. ELISA
Figure 11. WB
Figure 12. Others
Figure 13. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Recombinant Human Anti-RSV Antibody(AM14) Market Size (2020-2031) & (US$ Million)
Figure 15. Global Recombinant Human Anti-RSV Antibody(AM14) Sales (2020-2031) & (K Units)
Figure 16. Global Recombinant Human Anti-RSV Antibody(AM14) Average Price (US$/Unit) & (2020-2031)
Figure 17. Recombinant Human Anti-RSV Antibody(AM14) Report Years Considered
Figure 18. Recombinant Human Anti-RSV Antibody(AM14) Sales Share by Manufacturers in 2024
Figure 19. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Recombinant Human Anti-RSV Antibody(AM14) Players: Market Share by Revenue in Recombinant Human Anti-RSV Antibody(AM14) in 2024
Figure 21. Recombinant Human Anti-RSV Antibody(AM14) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Recombinant Human Anti-RSV Antibody(AM14) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country (2020-2031)
Figure 24. North America Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Country (2020-2031)
Figure 25. United States Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country (2020-2031)
Figure 28. Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Country (2020-2031)
Figure 29. Germany Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Region (2020-2031)
Figure 36. China Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country (2020-2031)
Figure 44. Latin America Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Recombinant Human Anti-RSV Antibody(AM14) by Type (2020-2031)
Figure 54. Global Revenue Market Share of Recombinant Human Anti-RSV Antibody(AM14) by Type (2020-2031)
Figure 55. Global Recombinant Human Anti-RSV Antibody(AM14) Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Recombinant Human Anti-RSV Antibody(AM14) by Application (2020-2031)
Figure 57. Global Revenue Market Share of Recombinant Human Anti-RSV Antibody(AM14) by Application (2020-2031)
Figure 58. Global Recombinant Human Anti-RSV Antibody(AM14) Price (US$/Unit) by Application (2020-2031)
Figure 59. Recombinant Human Anti-RSV Antibody(AM14) Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed